Yekaterina Chudnovsky - Jun 20, 2025 Form 4 Insider Report for Immix Biopharma, Inc. (IMMX)

Signature
/s/ Yekaterina Chudnovsky
Stock symbol
IMMX
Transactions as of
Jun 20, 2025
Transactions value $
$0
Form type
4
Date filed
6/23/2025, 04:57 PM
Previous filing
Jun 4, 2025

Reporting Owners (1)

Name Relationship Address Signature Signature date CIK
Chudnovsky Yekaterina Director, 10%+ Owner C/O IMMIX BIOPHARMA, INC., 11400 WEST OLYMPIC BLVD., SUITE 200, LOS ANGELES /s/ Yekaterina Chudnovsky 2025-06-23 0001979324

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
holding IMMX Common Stock 3.24M Jun 20, 2025 Held by GKCC, LLC F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction IMMX Stock Option (Right to Buy) Award $0 +33K $0.00 33K Jun 20, 2025 Common Stock 33K $2.24 Direct F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Yekaterina (Katie) Chudnovsky is the sole member and manager of GKCC, LLC and may be deemed to beneficially own the shares held by GKCC, LLC.
F2 The Stock Option will vest in twelve (12) equal monthly installments following the date of grant, subject to the Reporting Person's continued service on the Board of Directors.